Articles

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study

Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Bioengineering, Rice University, Houston, TX, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Biophysics, University of California, Berkeley, CA, USA
Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX, USA
University of Southern California, Los Angeles, CA, USA
Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA
Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA
Nemours Center for Cancer and Blood Disorders, Emory University, Atlanta GA, USA
University of Southern California, Los Angeles, CA, USA
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Department of Biomedical Engineering, The University of Texas at San Antonio, USA;
Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Haematologica Early view Jan 13, 2022 https://doi.org/10.3324/haematol.2021.279672